Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
14.04. | Theratechnologies juggles multiple suitors, including $255M offer from CDMO Future Pak | ||
11.04. | Navigating Retail and Specialty Lite Success: How Your Pharmacy Strategy Impacts Brand Performance | ||
11.04. | Amgen pads Imdelltra's case in tough-to-treat lung cancer subtype with phase 3 survival win | ||
11.04. | Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer | ||
11.04. | After Hetlioz's rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use | ||
11.04. | RFK Jr. looks to find cause of 'autism epidemic' by September through massive HHS research push | ||
11.04. | Argenx stays on a roll with Vyvgart, gaining FDA nod for at-home prefilled syringe | ||
11.04. | As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay | ||
11.04. | Fierce Pharma Asia-Congress' US-China biotech report; NIH's database ban; GSK's ABL neuroscience deal | ||
11.04. | As work on massive US plant continues, Kyowa Kirin wraps up construction of $118M biologics plant in Japan | ||
10.04. | Following pledges from Lilly and J&J, Novartis unveils $23B US investment to beef up manufacturing, R&D | ||
10.04. | Alzheimer's Association expands PSA campaign about early dementia signs to focus on Black Americans | ||
10.04. | Merck granted Rob Davis a pay boost to $23.2M, inching CEO's 2024 compensation closer to large pharma peers | ||
10.04. | Sun Pharma snags appeals win over Incyte, clearing way for US launch of alopecia med Leqselvi | ||
10.04. | Few psych drugs from past decade are on HCPs' radars: survey | ||
09.04. | CDMO PharmaLogic takes majority stake in Norway's Agilera to boost global radiopharma footprint | ||
09.04. | Annexon rolls out Guillain-Barré awareness campaign for HCPs amid promising results for targeted therapy | ||
09.04. | Mucinex maker Reckitt lets go of 190 staffers in NJ while Organon lays off 93 amid restructuring efforts | ||
09.04. | BMS prevails in antitrust lawsuit over its defense of multiple myeloma blockbuster Pomalyst | ||
09.04. | Pharma stocks slip as Trump renews threats of 'major' pharmaceutical tariff | ||
09.04. | DHL earmarks €2B to enhance biopharma cold chain operations as demand grows | ||
08.04. | Rocket boosts preparations for gene therapy launch with new commercial chief from J&J, AstraZeneca | ||
08.04. | RFK Jr. promotes measles vaccine as Texas outbreak continues | ||
08.04. | As Trump threatens tariffs on drugs, industry warns EU of $100B-plus pharma exodus to US | ||
08.04. | Novo Nordisk plugs more than $1B into upgrade of Brazilian manufacturing operations for injectable drugs, including GLP-1s |